Teijaro_Lab Profile Banner
Teijaro Lab Profile
Teijaro Lab

@Teijaro_Lab

Followers
386
Following
78
Media
10
Statuses
51

Chronic viral infections, Chemical Immunology, and immuno-oncology @ScrippsResearch

La Jolla, San Diego
Joined March 2018
Don't wanna be here? Send us removal request.
@Teijaro_Lab
Teijaro Lab
8 months
RT @LabWaggoner: Dysregulated ISG15 production and signaling during persistent LCMV infection drives lethal immune pathology, representing….
0
4
0
@Teijaro_Lab
Teijaro Lab
1 year
Congrats to everyone involved. @andyjminn, @EJohnWherry, @divijmathew, @zakjerry1 and @Isa57569543. Two great complimentary studies that hopefully will catalyze better treatments for patients in need soon! 👏.
@ScienceMagazine
Science Magazine
1 year
In two separate Science studies, researchers report that combining JAK inhibitors with checkpoint inhibitor immunotherapy enhances cancer patient response. Learn more ⬇️.📄: 📄: #SciencePerspective:
Tweet media one
1
0
15
@Teijaro_Lab
Teijaro Lab
1 year
RT @NatureBiotech: JAK inhibitors enhance anti–PD-1 immunotherapy by modulating T cell exhaustion and inflammatory signaling, as shown in p….
0
23
0
@Teijaro_Lab
Teijaro Lab
1 year
Proud of my two post-docs on their Science paper demonstrating JAK inhibitors can promote better anti-tumor responses in combination with checkpoint immunotherapy. Well done Jerry and Isa as well as all the authors! Special thanks to Dr. Veronika Bachanova for running the trial!.
@scrippsresearch
Scripps Research
1 year
A new @ScienceMagazine study led by Prof. John Teijaro, PhD, found that combining ruxolitinib, an approved drug, with checkpoint inhibitors supercharged T-cell responses. This could transform #cancer treatment, especially for tough-to-treat cancers. More:
Tweet media one
3
2
25
@Teijaro_Lab
Teijaro Lab
2 years
Pleased to see this one in print. What a journey with the parker lab @_chrisgparker_! Great example of merging chemical biology and immunology to generate an exciting tool to probe the immune response. Congrats to everyone involved and all the hard work!!.
1
3
21
@Teijaro_Lab
Teijaro Lab
2 years
RT @_chrisgparker_: Excited to share the final version in.@nchembio. Lots more mechanistic insights & characterization, including our inhib….
0
25
0
@Teijaro_Lab
Teijaro Lab
3 years
Humbled to be a part of this newest venture with great colleagues Ben Cravatt, Chris Parker and Stuart Schreiber. Looking forward to what lies ahead!.
@FierceBiotech
FierceBiotech
3 years
Belharra Therapeutics is finally ready to rise out of stealth with $130 million in capital and a multi-year collaboration with Genentech.
1
1
19
@Teijaro_Lab
Teijaro Lab
3 years
Excited to share work with our lab and Parker lab @_chrisgparker_ on the development and characterization of the first Slc15a4 inhibitors.
0
2
16
@Teijaro_Lab
Teijaro Lab
3 years
Myeloid reprogramming by JAK inhibition enhances checkpoint blockade therapy
0
0
3
@Teijaro_Lab
Teijaro Lab
4 years
RT @CellChemBiol: Check out the review by @_chrisgparker_ from @scrippsresearch on the integration #phenotypic #screening and #chemoproteom….
0
5
0
@Teijaro_Lab
Teijaro Lab
4 years
RT @scrippsresearch: Congratulations to @EOSaphire on being newly appointed as President and CEO @ljiresearch. A former graduate student an….
0
6
0
@Teijaro_Lab
Teijaro Lab
4 years
RT @NatRevImmunol: COVID-19 vaccines: modes of immune activation and future challenges
Tweet media one
0
156
0
@Teijaro_Lab
Teijaro Lab
5 years
Merry Christmas and Happy Holidays from all of us in the Teijaro Lab!.
0
0
13
@Teijaro_Lab
Teijaro Lab
5 years
Great example of basic research at Scripps and the Calibr drug discovery engine coming together to advance medicines for human disease. Watch this space. Congrats to all involved!.
@scrippsresearch
Scripps Research
5 years
STING attack on #cancer! In work by @Teijaro_Lab & Lairson Lab, Scripps Research scientists discover a drug that can activate the immune-boosting protein STING. Efficacy against #melanoma shows its potential as a future #anticancer therapy @ScienceMagazine
Tweet media one
0
0
7
@Teijaro_Lab
Teijaro Lab
5 years
Great day for the lab! Our collaborative work with Luke Larson's lab and Calibr came out today in Science! Congratulations to Vincent, Emily, Ying, and the whole team! We identified and characterized a novel, anti-tumor STING agonist, SR-717. Read it here:
Tweet media one
Tweet media two
Tweet media three
Tweet media four
8
12
57
@Teijaro_Lab
Teijaro Lab
5 years
Great collaborative effort! #ScrippsResearch #IAVI #UCSD.Find the paper here:
Tweet media one
Tweet media two
0
2
11
@Teijaro_Lab
Teijaro Lab
5 years
Tour de force!.
@bxv_imm
bxv_imm
5 years
Rapid isolation of potent SARS-CoV-2 neutralizing antibodies and protection in a small animal model
0
2
10
@Teijaro_Lab
Teijaro Lab
5 years
RT @bxv_imm: Rapid isolation of potent SARS-CoV-2 neutralizing antibodies and protection in a small animal model
0
3
0
@Teijaro_Lab
Teijaro Lab
5 years
The latest story from our lab describing the detrimental effects of extracelluar ISG15 in the lungs during viral infection is on BioRxiv now! Congratulations to our postdoc Namir Shaabani, who is the first author! Check it out here:
Tweet media one
Tweet media two
Tweet media three
1
4
28
@Teijaro_Lab
Teijaro Lab
5 years
RT @mmw_lmw: Wendy L Havran, 1955-2020 | With heavy hearts, we mourn the sudden passing of a very dear friend on January 20, 2020 | An exc….
0
4
0